377 related articles for article (PubMed ID: 18489980)
1. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
Francis M; Langhan T; Prosser J; Hoffman R
Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
[No Abstract] [Full Text] [Related]
2. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR
Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782
[TBL] [Abstract][Full Text] [Related]
3. Long-acting sulfonylureas -- long-acting hypoglycaemia.
Veitch PC; Clifton-Bligh RJ
Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
[No Abstract] [Full Text] [Related]
4. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
Vallurupalli S
Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
[TBL] [Abstract][Full Text] [Related]
5. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
Clerc D; Hugli O; Trueb L; Yersin B
Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
[TBL] [Abstract][Full Text] [Related]
6. Octreotide therapy for nateglinide-induced hypoglycemia.
Sherk DK; Bryant SM
Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765
[No Abstract] [Full Text] [Related]
7. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
Crawford BA; Perera C
Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835
[No Abstract] [Full Text] [Related]
8. Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes.
Braatvedt GD
N Z Med J; 1997 May; 110(1044):189-90. PubMed ID: 9201206
[No Abstract] [Full Text] [Related]
9. The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.
Holstein A; Hahn M; Stumvoll M; Kovacs P
Horm Metab Res; 2009 May; 41(5):387-90. PubMed ID: 19214942
[TBL] [Abstract][Full Text] [Related]
10. Emergency management of oral hypoglycemic drug toxicity.
Rowden AK; Fasano CJ
Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
[TBL] [Abstract][Full Text] [Related]
11. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
12. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Holstein A; Hammer C; Hahn M; Kulamadayil NS; Kovacs P
Expert Opin Drug Saf; 2010 Sep; 9(5):675-81. PubMed ID: 20553106
[TBL] [Abstract][Full Text] [Related]
13. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening.
Earle KE; Rushakoff RJ; Goldfine ID
Diabetes Technol Ther; 2003; 5(3):449-51. PubMed ID: 12828829
[TBL] [Abstract][Full Text] [Related]
14. Exorcising the specter of nighttime hypoglycemia.
Scheiner G
Diabetes Self Manag; 2012; 29(1):16, 18-20. PubMed ID: 22482132
[No Abstract] [Full Text] [Related]
15. Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
Barkin JA; Block HM; Mendez PE
Pancreas; 2013 May; 42(4):722-3. PubMed ID: 23591434
[No Abstract] [Full Text] [Related]
16. Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
McLaughlin SA; Crandall CS; McKinney PE
Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104
[TBL] [Abstract][Full Text] [Related]
17. [Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].
Furukawa H; Ishida H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():357-61. PubMed ID: 12387018
[No Abstract] [Full Text] [Related]
18. Drug-induced hypoglycaemia.
Prescrire Int; 2009 Apr; 18(100):67. PubMed ID: 19585724
[No Abstract] [Full Text] [Related]
19. [Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition].
Carlsen SM
Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3079-82. PubMed ID: 9381441
[TBL] [Abstract][Full Text] [Related]
20. [Hardly any hypoglycemias, constant weight--and still cost effective].
MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
